Table of Contents Author Guidelines Submit a Manuscript
Complexity
Volume 2018, Article ID 1656273, 12 pages
https://doi.org/10.1155/2018/1656273
Research Article

Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer

Guangdong Key Laboratory of IoT Information Technology, School of Automation, Guangdong University of Technology, Guangzhou, Guangdong, China

Correspondence should be addressed to Shengli Xie; nc.ude.tudg@eixlhs

Received 5 October 2017; Revised 13 May 2018; Accepted 23 May 2018; Published 12 June 2018

Academic Editor: Vittorio Loreto

Copyright © 2018 Xin Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Perou, T. Sørlie, M. B. Eisen et al., “Molecular portraits of human breast tumours,” Nature, vol. 406, no. 6797, pp. 747–752, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Senkus, S. Kyriakides, S. Ohno et al., “Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 26, Supplement 5, pp. v8–v30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. A. S. Coates, E. P. Winer, A. Goldhirsch et al., “Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the primary therapy of early breast cancer 2015,” Annals of Oncology, vol. 26, no. 8, pp. 1533–1546, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Clarke, S. F. Madden, P. Doolan et al., “Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis,” Carcinogenesis, vol. 34, no. 10, pp. 2300–2308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Zhu, Y. Ding, C. Y. Chen et al., “MetaDCN: meta-analysis framework for differential co-expression network detection with an application in breast cancer,” Bioinformatics, vol. 33, no. 8, pp. 1121–1129, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Nazarieh, A. Wiese, T. Will, M. Hamed, and V. Helms, “Identification of key player genes in gene regulatory networks,” BMC Systems Biology, vol. 10, no. 1, p. 88, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Yang, Y. Xiang, K. Xie, and Y. Lai, “Adaptive method for nonsmooth nonnegative matrix factorization,” IEEE Transactions on Neural Networks and Learning Systems, vol. 28, no. 4, pp. 948–960, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Yang, Y. Zhang, Y. Xiang, W. Yan, and S. Xie, “Non-negative matrix factorization with dual constraints for image clustering,” IEEE Transactions on Systems, Man, and Cybernetics: Systems, pp. 1–10, 2018. View at Publisher · View at Google Scholar
  9. A. H. Tong, G. Lesage, G. D. Bader et al., “Global mapping of the yeast genetic interaction network,” Science, vol. 303, no. 5659, pp. 808–813, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. G. A. Pavlopoulos, M. Secrier, C. N. Moschopoulos et al., “Using graph theory to analyze biological networks,” BioData Mining, vol. 4, no. 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Guelzim, S. Bottani, P. Bourgine, and F. Kepes, “Topological and causal structure of the yeast transcriptional regulatory network,” Nature Genetics, vol. 31, no. 1, pp. 60–63, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Evans, F. Y. Feng, and A. M. Chinnaiyan, “The bright side of dark matter: lncRNAs in cancer,” The Journal of Clinical Investigation, vol. 126, no. 8, pp. 2775–2782, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Lu, G. Zhu, C. Zhang et al., “Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer,” Breast Cancer Research and Treatment, vol. 136, no. 3, pp. 875–883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Meseure, S. Vacher, F. Lallemand et al., “Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer,” British Journal of Cancer, vol. 114, no. 12, pp. 1395–1404, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Wu, Q. Xu, H. Zhang et al., “A new avenue for obtaining insight into the functional characteristics of long noncoding RNAs associated with estrogen receptor signaling,” Scientific Reports, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Langfelder, B. Zhang, and S. Horvath, “Defining clusters from a hierarchical cluster tree: the dynamic tree cut package for R,” Bioinformatics, vol. 24, no. 5, pp. 719-720, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Zhang and S. Horvath, “A general framework for weighted gene co-expression network analysis,” Statistical Applications in Genetics and Molecular Biology, vol. 4, no. 1, 2005. View at Publisher · View at Google Scholar
  18. S. Anders and W. Huber, “Differential expression analysis for sequence count data,” Genome Biology, vol. 11, no. 10, p. R106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. S. Huang, C. C. Chang, S. S. Lee, Y. S. Jou, and H. M. Shih, “Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression,” Oncotarget, vol. 7, no. 28, pp. 43256–43266, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Vincent-Salomon, C. Ganem-Elbaz, E. Manie et al., “X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors,” Cancer Research, vol. 67, no. 11, pp. 5134–5140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Pang, J. Hu, G. Zhang et al., “Dysregulated long intergenic non-coding RNA modules contribute to heart failure,” Oncotarget, vol. 7, no. 37, pp. 59676–59690, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Sharan, I. Ulitsky, and R. Shamir, “Network-based prediction of protein function,” Molecular Systems Biology, vol. 3, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Huarte, M. Guttman, D. Feldser et al., “A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response,” Cell, vol. 142, no. 3, pp. 409–419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Yang, Y. H. Liu, S. Y. Dong et al., “A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer,” Biochemical and Biophysical Research Communications, vol. 470, no. 3, pp. 479–483, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Gyorffy, A. Lanczky, A. C. Eklund et al., “An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients,” Breast Cancer Research and Treatment, vol. 123, no. 3, pp. 725–731, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Li, L. Han, P. Roebuck et al., “TANRIC: an interactive open platform to explore the function of lncRNAs in Cancer,” Cancer Research, vol. 75, no. 18, pp. 3728–3737, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Qu, J. Cui, Y. Harata-Lee et al., “Identification of candidate anti-cancer molecular mechanisms of compound Kushen injection using functional genomics,” Oncotarget, vol. 7, no. 40, pp. 66003–66019, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. J. R. Prensner, M. K. Iyer, A. Sahu et al., “The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex,” Nature Genetics, vol. 45, no. 11, pp. 1392–1398, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. D. He, J. Wang, Y. Lu et al., “LncRNA functional networks in oligodendrocytes reveal stage-specific myelination control by an lncOL1/Suz12 complex in the CNS,” Neuron, vol. 93, no. 2, pp. 362–378, 2017. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Li, J. Xie, C. Shen et al., “Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma,” Oncogene, vol. 35, no. 12, pp. 1575–1584, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Kim, R. Cui, Y. J. Jeon, P. Fadda, H. Alder, and C. M. Croce, “MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression,” Oncotarget, vol. 6, no. 22, pp. 18780–18789, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Karra, H. Repo, I. Ahonen et al., “Cdc20 and securin overexpression predict short-term breast cancer survival,” British Journal of Cancer, vol. 110, no. 12, pp. 2905–2913, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Y. Han, Y. K. Han, G.-Y. Park, S. D. Kim, and C. Geun Lee, “Bub1 is required for maintaining cancer stem cells in breast cancer cell lines,” Scientific Reports, vol. 5, no. 1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Mukherjee, C. Joseph, M. Craze, E. Chrysanthou, and I. O. Ellis, “The role of BUB and CDC proteins in low-grade breast cancers,” The Lancet, vol. 385, p. S72, 2015. View at Publisher · View at Google Scholar
  36. F. Al-Ejeh, P. T. Simpson, J. M. Sanus et al., “Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer,” Oncogenesis, vol. 3, no. 4, p. e100, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Mason, X. Wei, G. C. Fletcher et al., “Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 12, pp. 3127–3132, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Yata, J. Y. Bleuyard, R. Nakato et al., “BRCA2 coordinates the activities of cell-cycle kinases to promote genome stability,” Cell Reports, vol. 7, no. 5, pp. 1547–1559, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. N. E. Bhola, V. M. Jansen, S. Bafna et al., “Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer,” Cancer Research, vol. 75, no. 2, pp. 405–414, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Maire, F. Nemati, M. Richardson et al., “Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer,” Cancer Research, vol. 73, no. 2, pp. 813–823, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Feng, J. Zhang, W. Su et al., “Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer,” Scientific Reports, vol. 7, no. 1, p. 2982, 2017. View at Publisher · View at Google Scholar · View at Scopus